Location - SAS ELYPSE
主要な指数・指標 SAS ELYPSE
Activities - SAS ELYPSE
企業活動
他の分類
NAF Rev.2 (FR 2008) : Support activities to performing arts (9002Z)
NACE Rev.2 (EU 2008) : Support activities to performing arts (9002)
Conventions Collectives : Convention collective Entreprises au service de la création et de l’événement du 27 juin 2024 (3252)
ISIC 4 (WORLD) : Creative, arts and entertainment activities (9000)
NACE Rev.2.1 (EU 2025) : Other support activities to arts and performing arts (9039)
Follow us - SAS ELYPSE
| Discover more on our Website | Website available |
|---|
Kompass membership
| Kompass ID? | FR0810168 |
|---|
Legal information - SAS ELYPSE
| Type | Information available as an option |
|---|---|
| 設立年 | Information available as an option|
| Legal form | SAS, société par actions simplifiée |
| Activity (NAF08) | Support activities to performing arts (9002Z) |
| Corporate capital | Information available as an option|
| SIREN | 408 780 005 |
| SIRET (Siège) | 408 780 005 00042 |
| VAT no |
FR67 408780005 |
| No employees (address) | 0名〜9名 Employees |
| No employees | 0名〜9名 Employees |
Other Companies recommended by Kompass:
Looking for new B2B Leads ?
Purchase a Company list with the executives and contact details
You might also like:
Need help finding the right information ? Let us guide you to the best solutions !
I am looking for :
The shortest path to your future customers and suppliers
"I would recommend EasyBusiness to all sales teams."
Test EasyBusiness for 14 days for free
No payment or credit card required
All-in-one prospecting solution designed to improve your productivity
Find your next customer today! Your shortcut to faster, more targeted and successful lead generation
Register for free and turn reliable data into real business opportunities
Your data is used to recontact you or send you communications and may be processed by Kompass, for the purposes of legitimate interest (Article 6 1.f of the GDPR).
You may object to its processing by email: dpo@kompass.com.
Find out more: see our privacy policy.